Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleUsing quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial.AuthorsDiaby, Vakaramoko; Adunlin, Georges; Ali, Askal; Tawk, RimaPublicationBreast Cancer Research & Treatment, 2014, Vol 146, Issue 3, p669ISSN0167-6806Publication typeReportDOI10.1007/s10549-014-3047-y